Evotec Se Stock Fundamentals
| EVOTF Stock | USD 10.18 3.65 26.39% |
Evotec SE fundamentals help investors to digest information that contributes to Evotec SE's financial success or failures. It also enables traders to predict the movement of Evotec Pink Sheet. The fundamental analysis module provides a way to measure Evotec SE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evotec SE pink sheet.
Evotec |
Evotec SE Company Operating Margin Analysis
Evotec SE's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Evotec SE Operating Margin | (0.01) % |
Most of Evotec SE's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evotec SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Evotec SE has an Operating Margin of -0.0054%. This is 99.98% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 99.9% lower than that of the firm.
Evotec SE Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evotec SE's current stock value. Our valuation model uses many indicators to compare Evotec SE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evotec SE competition to find correlations between indicators driving Evotec SE's intrinsic value. More Info.Evotec SE is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Evotec SE by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Evotec SE's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evotec SE's earnings, one of the primary drivers of an investment's value.Evotec Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evotec SE's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Evotec SE could also be used in its relative valuation, which is a method of valuing Evotec SE by comparing valuation metrics of similar companies.Evotec SE is currently under evaluation in operating margin category among related companies.
Evotec Fundamentals
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0012 | |||
| Profit Margin | (0.26) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 2.68 B | |||
| Shares Outstanding | 176.95 M | |||
| Shares Owned By Insiders | 9.86 % | |||
| Shares Owned By Institutions | 66.12 % | |||
| Price To Earning | 347.66 X | |||
| Price To Book | 2.28 X | |||
| Price To Sales | 4.35 X | |||
| Revenue | 618.03 M | |||
| Gross Profit | 151.54 M | |||
| EBITDA | 316.63 M | |||
| Net Income | 215.51 M | |||
| Cash And Equivalents | 887.88 M | |||
| Cash Per Share | 5.03 X | |||
| Total Debt | 326.34 M | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 3.57 X | |||
| Book Value Per Share | 6.95 X | |||
| Cash Flow From Operations | 122.24 M | |||
| Earnings Per Share | 0.04 X | |||
| Number Of Employees | 4.71 K | |||
| Beta | 1.01 | |||
| Market Capitalization | 4.14 B | |||
| Total Asset | 2.24 B | |||
| Retained Earnings | (618.9 M) | |||
| Working Capital | 42.51 M | |||
| Current Asset | 68.96 M | |||
| Current Liabilities | 26.45 M | |||
| Z Score | 7.2 | |||
| Net Asset | 2.24 B |
About Evotec SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evotec SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evotec SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evotec SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany. EVOTEC SE operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4521 people.
Pair Trading with Evotec SE
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evotec SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will appreciate offsetting losses from the drop in the long position's value.Moving against Evotec Pink Sheet
| 0.84 | TEVA | Teva Pharmaceutical | PairCorr |
| 0.42 | LRDG | Lord Global Corp | PairCorr |
The ability to find closely correlated positions to Evotec SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evotec SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evotec SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evotec SE to buy it.
The correlation of Evotec SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evotec SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evotec SE moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evotec SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Evotec Pink Sheet analysis
When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |